A detailed history of Boothbay Fund Management, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 423,522 shares of IMUX stock, worth $457,403. This represents 0.02% of its overall portfolio holdings.

Number of Shares
423,522
Previous 423,522 -0.0%
Holding current value
$457,403
Previous $470,000 48.51%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $390,371 - $523,919
342,431 Added 422.28%
423,522 $559,000
Q3 2023

Nov 14, 2023

SELL
$1.35 - $2.87 $48,652 - $103,431
-36,039 Reduced 30.77%
81,091 $119,000
Q4 2022

Feb 14, 2023

BUY
$1.13 - $10.8 $132,356 - $1.27 Million
117,130 New
117,130 $163,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $55,811 - $218,429
17,831 New
17,831 $62,000
Q4 2021

Feb 14, 2022

SELL
$7.34 - $10.25 $128,222 - $179,057
-17,469 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$8.05 - $13.29 $140,625 - $232,163
17,469 New
17,469 $155,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $33M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.